DCF Advisers’s Prothena Corp PRTA Stock Holding History
Bought
Maintained
Sold
Other funds holding PRTA
RCMNY
ACM
VPM
PAI
DCF Advisers's PRTA Position: Q1 2026 in Review
DCF Advisers reduced its Prothena Corp (PRTA) stake by 63% in Q1 2026, selling an estimated $1.12M and leaving 73,247 shares worth $712K. The position accounts for 0.19% of the portfolio, ranked #67.
DCF Advisers first reported a position in PRTA in Q1 2021 and has held it in 21 quarters since. The position peaked at $5.79M in Q2 2023. 185 funds tracked by Wall St. Rank hold PRTA as of Q1 2026.
- DCF Advisers held 73,247 shares of Prothena Corp worth $712K as of Q1 2026.
- DCF Advisers sold 122,500 Prothena Corp shares in Q1 2026, an estimated $1.12M.
- Prothena Corp made up 0.19% of DCF Advisers's portfolio in Q1 2026, its #67 holding.
- DCF Advisers first reported a position in Prothena Corp in Q1 2021 and has held it in 21 quarters since.
- DCF Advisers's Prothena Corp position peaked at $5.79M in Q2 2023.
- 185 funds tracked by Wall St. Rank held Prothena Corp as of Q1 2026.
Based on DCF Advisers's 13F filing for Q1 2026, filed 11 May 2026.